The salty kiss of the disease
Fibrocystic disease of the pancreas may go unnoticed and cause havoc in the body. The test that diagnosed in time.
Salt in the sweat, the skin and salt right out of the sea, may indicate one of the most common genetic problems and serious white: fibrocystic disease of the pancreas.
"It's the genetic disease, inherited autosomal recessive most frequent in whites," says Dr. Omar Pivetta, medical geneticist, adding that the cause is a mutation of the CFTR gene, which is involved in the production of sweat, gastric juice and mucus. In general, results in the formation and accumulation of a thick, sticky mucus in the lungs, intestines, pancreas and liver in particular. Difficulty breathing is the most common symptom, "by causing chronic lung infection in most cases," says the specialist.
The incidence in Argentina is higher than the average in Latin America: 1 in 30 healthy people are carriers of genetic mutation. This is because "the constitution of our population, predominantly Caucasian," says Dr. Pivetta. Its early diagnosis is crucial, as "70% of children who receive no care die before reaching the year while, with treatment that exist today, 50% live more than 46 years," according geneticist.
In the detection plays a central role of the typical symptoms of the disease fibroquísitca: large concentrations of salt in sweat and through the skin, which is why it is known as the "kissing disease salty." From this observation was invented sweat proof, as indispensable as absent.
Measure the excess salt
There are several methods for detecting fibrocystic disease, the first of which is binding for some years is the examination of newborn screening. It draws a drop of blood from newborn heel at all levels and there is a pancreatic enzyme, trypsin immuno-reactive. But this test is not sufficient to confirm the diagnosis, and here comes in the "sweat test".
The test takes about 40 minutes and shows the concentration of salt that removes abnormal body sweating. Is prescribed for children who had a positive neonatal screening, or for any child or adult with suspected symptoms.
Despite the effectiveness of this study, Dr. Pivetta laments that "in few places is done correctly." "In Buenos Aires, for example, no more than three sites do so reliably, and the country's total is less than 10 sites. The key is to be done, and we do well here, "he says.
How is after a diagnosis of fibrocystic disease? The doctor explained that treatment was "symptomatic and life": "In summer it is more water and more salt to the patient, because it has more risk of heat stroke and dehydration. And to address pulmonary infection, apply sprays and kinesitherapy to release the mucus.
Emphasizes the importance of identifying the problem in time to avoid "medical errors, lost time and increased lung damage."
Symptoms
Excessively salty sweat.
Retardation in growth.
Difficulty gaining weight.
Abundant and oily diarrhea.
Persistent respiratory infections.
Chronic cough.
Male sterility.
* Source: FIPAN (Asociación Argentina de Combat fibrocystic disease of the pancreas)
Sunday, February 15, 2009
Saturday, February 14, 2009
300,000 Bizkaian will benefit from the new service appointment reminders by SMS Hospital Galdakao-using it.
- The mechanism to remind patients, with 72 hours in advance of the appointment
- The new program not only andalusia Hospital Galdakao - Usansolo but extends to the five outpatient Durango, Llodio, Gernika, Basauri Galdakao and operating in its area of influence
- The user can cancel your appointment to receive the message
- Nearly 300,000 people will benefit from this new service.
What day, what time and where I have quoted. The three most common uncertainties quoted are for a patient response to the new service appointment reminders by SMS activated at the Hospital of Galdakao - Usansolo starting next Monday, December 15, 2009. Three days prior to referral to the specialist, the hospital sent the patient a message to your mobile phone which shows the date, time and expertise for which he is quoted.
The service, which during the first quarter of 2009 also put the warning voice messages through the phone, aims to improve care in the hospital, speeding up the procedures for managing schedules and reduce failure rates to the event that some services may reach fourteen percent, says Begoña Segurola, deputy director of Organization and Systems Hospital Galdakao - Usansolo.
The service has a significant field. Not for nothing is not limited exclusively to the health center said, but extends to the five outpatient Durango, Llodio, Gernika, Basauri Galdakao and operating in its area of influence. The content of the message will specify the name of the center that the patient has to go.
It is a capital case, given that the catchment area of Hospital Galdakao includes a population of 300,000, a figure similar to the number of annual appointments made by the Hospital Galdakao - Usansolo and five clinics in addition to this initiative . The system aims to provide an interactive way, the user can cancel the appointment, which will allow another patient to use that quote, by a reply message (the estimated price of 0.15 euros) and the system itself has a safety mechanism that repeats the sending of SMS, 48 hours before the appointment, if it detects that the first consignment has not been opened on the mobile phone receiver.
In the event that a user wants to dispense with this service must apply via the Patient Care Hospital.
- The new program not only andalusia Hospital Galdakao - Usansolo but extends to the five outpatient Durango, Llodio, Gernika, Basauri Galdakao and operating in its area of influence
- The user can cancel your appointment to receive the message
- Nearly 300,000 people will benefit from this new service.
What day, what time and where I have quoted. The three most common uncertainties quoted are for a patient response to the new service appointment reminders by SMS activated at the Hospital of Galdakao - Usansolo starting next Monday, December 15, 2009. Three days prior to referral to the specialist, the hospital sent the patient a message to your mobile phone which shows the date, time and expertise for which he is quoted.
The service, which during the first quarter of 2009 also put the warning voice messages through the phone, aims to improve care in the hospital, speeding up the procedures for managing schedules and reduce failure rates to the event that some services may reach fourteen percent, says Begoña Segurola, deputy director of Organization and Systems Hospital Galdakao - Usansolo.
The service has a significant field. Not for nothing is not limited exclusively to the health center said, but extends to the five outpatient Durango, Llodio, Gernika, Basauri Galdakao and operating in its area of influence. The content of the message will specify the name of the center that the patient has to go.
It is a capital case, given that the catchment area of Hospital Galdakao includes a population of 300,000, a figure similar to the number of annual appointments made by the Hospital Galdakao - Usansolo and five clinics in addition to this initiative . The system aims to provide an interactive way, the user can cancel the appointment, which will allow another patient to use that quote, by a reply message (the estimated price of 0.15 euros) and the system itself has a safety mechanism that repeats the sending of SMS, 48 hours before the appointment, if it detects that the first consignment has not been opened on the mobile phone receiver.
In the event that a user wants to dispense with this service must apply via the Patient Care Hospital.
Solidarity initiative to operate free of charge to people with eye problems and no financial resources.
The Christmas campaign is a joint initiative of NOVOVISIÓN already established and it has a great interest Sociomedical
It is the fourth year that this campaign is
Both preoperative tests such as the post is also free
Guarantees the confidentiality of data on applicants
Will be conducted a total of 20 interventions in 10 in Madrid and Murcia
As in recent years by this time NOVOVISIÓN conducted a solidarity campaign to settle the problems of vision to patients who, for economic reasons, are unable to access the services of an eye clinic in the first level.
To this end, the team conducted a NOVOVISIÓN twenty speeches for free and disinterested persons residing in the Community of Madrid (in addition to a dozen people in interventions of the Community of Murcia) to demonstrate an inability to pay. This action includes preoperative testing and any subsequent revisions. Specifically, we offer solutions refractive surgery (for cases of myopia, hyperopia and astigmatism) in the area of Ophthalmology.
"Convinced that better health is better quality of life, NOVOVISIÓN seek to extend this possibility to those who can not access it," said Ramon Gutierrez, Director of the Center. As he adds, "we realize that to reach the stakeholders, we need the media, hence we request your cooperation, as well those in need can access the benefits of this campaign."
Requirements and selection process
Among the requirements that are demanded to solicit aid for refractive surgery, candidates must:
- Present at the clinic (54 Paseo de la Castellana in Madrid, C / Jaime I, Murcia 2) documentation to support the economic difficulties for meeting the costs of these services (statement of family income)
- Photocopy of DNI
- Having more than 25 years.
- Living in the Community of Madrid or the Community of Murcia.
- Need any intervention that is not covered by social security benefits.
A committee composed of the Directorate of Medical and administrative NOVOVISIÓN evaluate the data provided by the candidates, giving special priority to the extent of the need for the services offered by this clinic and financial constraints of the stakeholders.
Applicants must submit documentation attesting to their status between December 29 and January 10 at the Paseo de la Castellana and 54 hours of 10.00am to 16.00 Monday to Friday. It is envisaged that the preoperative tests were conducted in mid-January to carry out the all selected at the end of this month or early February, in that day, NOVOVISIÓN open its doors to the press from the 11 in the morning and throughout the day.
In no event shall be exchanged by the interventions of its economic value or any other consideration. Guarantees the confidentiality of all information provided by applicants.
Clinical Reference
This is the third year NOVOVISIÓN conducted this joint initiative, with dozens of people who each call request this free service.
NOVOVISIÓN takes nearly a decade leading the research and clinical ophthalmology in Spain. This clinic specializes in eye treatments and was born in 1999, serving in all areas of visual health, applying the latest technology. It has been a pioneer in our country in the introduction of numerous techniques that have subsequently proved to be effective, such as laser surgery to correct visual defects or lenses at night.
Clinic NOVOVISIÓN in Madrid shares with the recently opened Clinical NOVOSALUD over 1,000 m2 for consultations, diagnostic areas, sterilization rooms, surgical site (with three operating rooms equipped for all types of interventions), area postoperative rooms expected, and other services as well as an exquisite and personalized treatment.
It is the fourth year that this campaign is
Both preoperative tests such as the post is also free
Guarantees the confidentiality of data on applicants
Will be conducted a total of 20 interventions in 10 in Madrid and Murcia
As in recent years by this time NOVOVISIÓN conducted a solidarity campaign to settle the problems of vision to patients who, for economic reasons, are unable to access the services of an eye clinic in the first level.
To this end, the team conducted a NOVOVISIÓN twenty speeches for free and disinterested persons residing in the Community of Madrid (in addition to a dozen people in interventions of the Community of Murcia) to demonstrate an inability to pay. This action includes preoperative testing and any subsequent revisions. Specifically, we offer solutions refractive surgery (for cases of myopia, hyperopia and astigmatism) in the area of Ophthalmology.
"Convinced that better health is better quality of life, NOVOVISIÓN seek to extend this possibility to those who can not access it," said Ramon Gutierrez, Director of the Center. As he adds, "we realize that to reach the stakeholders, we need the media, hence we request your cooperation, as well those in need can access the benefits of this campaign."
Requirements and selection process
Among the requirements that are demanded to solicit aid for refractive surgery, candidates must:
- Present at the clinic (54 Paseo de la Castellana in Madrid, C / Jaime I, Murcia 2) documentation to support the economic difficulties for meeting the costs of these services (statement of family income)
- Photocopy of DNI
- Having more than 25 years.
- Living in the Community of Madrid or the Community of Murcia.
- Need any intervention that is not covered by social security benefits.
A committee composed of the Directorate of Medical and administrative NOVOVISIÓN evaluate the data provided by the candidates, giving special priority to the extent of the need for the services offered by this clinic and financial constraints of the stakeholders.
Applicants must submit documentation attesting to their status between December 29 and January 10 at the Paseo de la Castellana and 54 hours of 10.00am to 16.00 Monday to Friday. It is envisaged that the preoperative tests were conducted in mid-January to carry out the all selected at the end of this month or early February, in that day, NOVOVISIÓN open its doors to the press from the 11 in the morning and throughout the day.
In no event shall be exchanged by the interventions of its economic value or any other consideration. Guarantees the confidentiality of all information provided by applicants.
Clinical Reference
This is the third year NOVOVISIÓN conducted this joint initiative, with dozens of people who each call request this free service.
NOVOVISIÓN takes nearly a decade leading the research and clinical ophthalmology in Spain. This clinic specializes in eye treatments and was born in 1999, serving in all areas of visual health, applying the latest technology. It has been a pioneer in our country in the introduction of numerous techniques that have subsequently proved to be effective, such as laser surgery to correct visual defects or lenses at night.
Clinic NOVOVISIÓN in Madrid shares with the recently opened Clinical NOVOSALUD over 1,000 m2 for consultations, diagnostic areas, sterilization rooms, surgical site (with three operating rooms equipped for all types of interventions), area postoperative rooms expected, and other services as well as an exquisite and personalized treatment.
The combination of lapatinib and letrozole delays the progression of metastatic breast cancer in postmenopausal women erbB2 +.
according to a study presented at an international conference on breast cancer
The combination of lapatinib (Tyverb ®) and letrozole (an aromatase inhibitor) as first-line treatment slows the progression of metastatic breast cancer erbB2 positive compared with letrozole alone [i], according to a study presented in San Antonio 31 Breast Cancer Symposium (SABCS).
Lapatinib (Tyverb ®) is available in Spain this month for breast cancer patients with advanced or metastatic erbB2 + tumor which had progressed after previous treatment with anthracyclines, taxanes and trastuzumab [ii] for metastatic disease and for which so far there was no other treatment alternative. This drug, GlaxoSmithKline (GSK) is administered to these patients in combination with capecitabine.
EGF30008 The study presented in SABCS is esnsayo a clinical phase III, double-blind, randomized, placebo involving 1286 postmenopausal women with metastatic breast cancer with hormone receptor positive. Some of the patients included in this study also expressed the receptor erbB2. The study patients received either letrozole 2.5 mg once a day plus lapatinib 1500 mg, or 2.5 mg of letrozole plus placebo. The first objective of this study was to verify the disease-free survival in the subgroup of people who had also overexpress the erbB2 receptor and the secondary variables such as progression-free survival in the group of patients. Other secondary variables were: overall response rate, clinical benefit rate, time to response, duration, overall survival, safety and quality of life. Hormone therapy was permitted only in the group receiving adjuvant treatment (1 year before entering the study).
The patients experienced 5.2 months increase in survival free of disease progression compared with women treated with letrozole alone (8.2 months vs. 3). Across the group that received lapatinib treatment with letrozole, irrespective of whether it was to overexpress the erbB2 receptor or not, the average progression-free survival was more than a month with letrozole alone (11.9 months vs. 10.9).
The combination of letrozole and lapatinib was safe and no serious adverse effects were identified. Adverse effects of grade 3 / 4 occurred in 2% of patients in the group receiving the combination as in monotherapy, and included diarrhea, back pain, fatigue and increased transaminases (ALT and AST).
The growth factor receptors, such as those belonging to the erbB family play a key role in growth and cell survival [iii]. The recipient can go to these proteins is a way to remove the tumor cells and prevent tumor growth. About 70% of breast cancers are hormone receptor positive and only one third of them responded to treatment with aromatase inhibitors. Even many of the responding tumors may become resistant, leading to tumor progression and, ultimately, the death of the patient [iv]. Recent studies have revealed interactions between hormone receptors and erbB receptors, as major contributors to the development of resistance, and have served as a baseline scenario for this study [v].
Breast cancer erbB2 +
Breast cancer erbB2 + affects almost half (44% -48%) of patients younger than 40 years and one quarter of all breast cancer patients [vi] [vii]. One of the most aggressive of worse prognosis and therefore at higher risk of recurrence and mortality. About half of patients with metastatic breast cancer erbB2 + does not respond to existing therapies to date and the most responsive patients show disease progression during the year following the tratamiento4 5. So far, no other therapeutic alternatives for these patients.
Unlike other treatments available for this type of cancer, lapatinb is the first oral targeted therapy, allowing patients to take treatment at home. Lapatinib presents a novel mechanism of action: it acts from inside the cell, inhibiting both andalusia andalusia ErbB1 and erbB2 receptor, both responsible for the growth and proliferation tumoral6 7. Being able to act from inside the cell, lapatinib is not affected by any changes or the presence of mutations in the extracellular domain of receptor8.
GlaxoSmithKline (GSK)
GSK is a pharmaceutical company engaged in research and development of new cancer treatments that can make important changes in the lives of patients. GSK has one of the portfolios of drugs in solid research oncology sector. The research effort GSK Oncology includes working with over 160 cancer centers worldwide. GSK is investigating various methods of treatment against cancer, both those focused on prevention, as in the palliative treatment, chemotherapy and targeted therapies against specific molecular targets.
The combination of lapatinib (Tyverb ®) and letrozole (an aromatase inhibitor) as first-line treatment slows the progression of metastatic breast cancer erbB2 positive compared with letrozole alone [i], according to a study presented in San Antonio 31 Breast Cancer Symposium (SABCS).
Lapatinib (Tyverb ®) is available in Spain this month for breast cancer patients with advanced or metastatic erbB2 + tumor which had progressed after previous treatment with anthracyclines, taxanes and trastuzumab [ii] for metastatic disease and for which so far there was no other treatment alternative. This drug, GlaxoSmithKline (GSK) is administered to these patients in combination with capecitabine.
EGF30008 The study presented in SABCS is esnsayo a clinical phase III, double-blind, randomized, placebo involving 1286 postmenopausal women with metastatic breast cancer with hormone receptor positive. Some of the patients included in this study also expressed the receptor erbB2. The study patients received either letrozole 2.5 mg once a day plus lapatinib 1500 mg, or 2.5 mg of letrozole plus placebo. The first objective of this study was to verify the disease-free survival in the subgroup of people who had also overexpress the erbB2 receptor and the secondary variables such as progression-free survival in the group of patients. Other secondary variables were: overall response rate, clinical benefit rate, time to response, duration, overall survival, safety and quality of life. Hormone therapy was permitted only in the group receiving adjuvant treatment (1 year before entering the study).
The patients experienced 5.2 months increase in survival free of disease progression compared with women treated with letrozole alone (8.2 months vs. 3). Across the group that received lapatinib treatment with letrozole, irrespective of whether it was to overexpress the erbB2 receptor or not, the average progression-free survival was more than a month with letrozole alone (11.9 months vs. 10.9).
The combination of letrozole and lapatinib was safe and no serious adverse effects were identified. Adverse effects of grade 3 / 4 occurred in 2% of patients in the group receiving the combination as in monotherapy, and included diarrhea, back pain, fatigue and increased transaminases (ALT and AST).
The growth factor receptors, such as those belonging to the erbB family play a key role in growth and cell survival [iii]. The recipient can go to these proteins is a way to remove the tumor cells and prevent tumor growth. About 70% of breast cancers are hormone receptor positive and only one third of them responded to treatment with aromatase inhibitors. Even many of the responding tumors may become resistant, leading to tumor progression and, ultimately, the death of the patient [iv]. Recent studies have revealed interactions between hormone receptors and erbB receptors, as major contributors to the development of resistance, and have served as a baseline scenario for this study [v].
Breast cancer erbB2 +
Breast cancer erbB2 + affects almost half (44% -48%) of patients younger than 40 years and one quarter of all breast cancer patients [vi] [vii]. One of the most aggressive of worse prognosis and therefore at higher risk of recurrence and mortality. About half of patients with metastatic breast cancer erbB2 + does not respond to existing therapies to date and the most responsive patients show disease progression during the year following the tratamiento4 5. So far, no other therapeutic alternatives for these patients.
Unlike other treatments available for this type of cancer, lapatinb is the first oral targeted therapy, allowing patients to take treatment at home. Lapatinib presents a novel mechanism of action: it acts from inside the cell, inhibiting both andalusia andalusia ErbB1 and erbB2 receptor, both responsible for the growth and proliferation tumoral6 7. Being able to act from inside the cell, lapatinib is not affected by any changes or the presence of mutations in the extracellular domain of receptor8.
GlaxoSmithKline (GSK)
GSK is a pharmaceutical company engaged in research and development of new cancer treatments that can make important changes in the lives of patients. GSK has one of the portfolios of drugs in solid research oncology sector. The research effort GSK Oncology includes working with over 160 cancer centers worldwide. GSK is investigating various methods of treatment against cancer, both those focused on prevention, as in the palliative treatment, chemotherapy and targeted therapies against specific molecular targets.
TEMPUR Med and Brown signed an alliance to offer an optimal solution to the medical sector in Spain.
The two companies have extensive experience in the manufacture of beds, mattresses and pillows that combine comfort and technology to hospitals and nursing homes.
TEMPUR-Pedic International, Inc., a global leader in the manufacture and distribution of mattresses and pillows viscoelastic material of high-end, has signed an alliance with the company-Pardo specializing in the development of electric-slatted frames to provide an optimal solution andalusia medical market in Spain. Patients have to stay in bed too long without changing position or with limited mobility, suffering from ulcers or pressure sores, will benefit from this agreement.
"Both companies have partnered in this project to propose to the medical industry the best solution to treat patients on a functional," said David Montgomery, Director of International Operations Tempura-Pedic International Inc. "By choosing to Brown, we are able provide the best for the healthcare market in Spain. "
In the photo: David Montgomery, Director of International Operations Tempura-Pedic International Inc (left) and Fernando Artero, CEO of Brown (right).
TEMPUR Med offers a wide range of items specially designed to prevent or treat pressure ulcers. The product range consists of mattresses and pillows to relieve pressure, and can be used in operating rooms and in rooms to rest and improve patient comfort and expedite recovery.
"When we asked for tempura estudiásemos the possibility of a partnership between two companies in the medical market, we did not have any doubt. We were confident that in Spain, without Tempura could not reach the highest level, "said Artero Fernando, Director General of Pardo.
Brown has developed a range of beds for hospitals and is now a major supplier of the Ministry of Health in Spain. In the'80s, Brown began to market a range of electric beds articulated that, today, are aimed at consumers looking for functional products that enhance comfort, health and quality of life. The slatted frames electric Pardo were awarded at the International Furniture Fair in Sydney in 2003 and received the award for best product motorized.
About Tempura-Pedic International Inc.
TEMPUR-Pedic International Inc. manufactures and distributes mattresses, pillows and other high-end products designed for the best rest, manufactured with the exclusive TEMPUR ® material that provides support to the entire body and helps relieve pressure on sensitive points. Tempura products for the medical industry are marketed under the name of tempura-Med. TEMPUR viscoelastic material is a high technology, originally developed by NASA in the'70s for its space program.
TEMPUR-Pedic International, Inc., a global leader in the manufacture and distribution of mattresses and pillows viscoelastic material of high-end, has signed an alliance with the company-Pardo specializing in the development of electric-slatted frames to provide an optimal solution andalusia medical market in Spain. Patients have to stay in bed too long without changing position or with limited mobility, suffering from ulcers or pressure sores, will benefit from this agreement.
"Both companies have partnered in this project to propose to the medical industry the best solution to treat patients on a functional," said David Montgomery, Director of International Operations Tempura-Pedic International Inc. "By choosing to Brown, we are able provide the best for the healthcare market in Spain. "
In the photo: David Montgomery, Director of International Operations Tempura-Pedic International Inc (left) and Fernando Artero, CEO of Brown (right).
TEMPUR Med offers a wide range of items specially designed to prevent or treat pressure ulcers. The product range consists of mattresses and pillows to relieve pressure, and can be used in operating rooms and in rooms to rest and improve patient comfort and expedite recovery.
"When we asked for tempura estudiásemos the possibility of a partnership between two companies in the medical market, we did not have any doubt. We were confident that in Spain, without Tempura could not reach the highest level, "said Artero Fernando, Director General of Pardo.
Brown has developed a range of beds for hospitals and is now a major supplier of the Ministry of Health in Spain. In the'80s, Brown began to market a range of electric beds articulated that, today, are aimed at consumers looking for functional products that enhance comfort, health and quality of life. The slatted frames electric Pardo were awarded at the International Furniture Fair in Sydney in 2003 and received the award for best product motorized.
About Tempura-Pedic International Inc.
TEMPUR-Pedic International Inc. manufactures and distributes mattresses, pillows and other high-end products designed for the best rest, manufactured with the exclusive TEMPUR ® material that provides support to the entire body and helps relieve pressure on sensitive points. Tempura products for the medical industry are marketed under the name of tempura-Med. TEMPUR viscoelastic material is a high technology, originally developed by NASA in the'70s for its space program.
Winter sports injuries and risk: some recommendations from experts of the Spanish Society of Sports Traumatology.
- The likelihood of injury is 3.9 injuries in 1000 skiers per day
- SETRADE recommend a good physical preparation and technique, but also enough rest before skiing
This year, cold and low temperatures have arrived in advance. When the mercury drops, the snow makes its first appearance, and that is when it is the start of winter sports, gaining particular prominence sports like skiing.
Many modalities practiced but the most popular and suitable for all ages are downhill skiing and snowboarding. The Society of Sports Traumatology (SETRADE) ensures that each of these activities require some physical demands and injury risks involves some very different.
Needless to say, when you start the ski season, many fans are thinking that too without throwing a track without fulfilling the conditions suitable for this sport that can be carried out in complete safety.
To SETRADE, one of the most basic measures to prevent injuries is standard practice throughout the year some kind of physical activity, to strengthen and maintain lists the most vulnerable when skiing (legs, arms and spine).
Emphasize that downhill skiing is more common in the ski resorts, although it requires a good physical condition and technique. Given that an estimated 200 million people worldwide practice the sport, the likelihood of injury is 2.6 to 3.9 injuries per 1,000 skiers per day. This high rate of injuries means that skiing is a sport with a higher risk lesion. "Most injuries in skiing are produced as a result of lack of fitness of the athlete. Because it is a seasonal sport and is not practiced all year, the risk of injury is more significant trauma in other sports. Skiing requires a physical and a specific training that few fans realize, "says Dr. Marchori Sanchez, president of the Society of Sports Traumatology.
To avoid suffering these injuries, the Society of Sports Traumatology (SETRADE) recommended before putting the skis:
- A good physical preparation throughout the year, playing some kind of activity, which mainly involve the joints, spine, limbs ...
- Technical preparation prior to acquiring a good command should take lessons with a specialized monitor.
- Availability of proper ski equipment in good condition, with good bindings and glasses covered with glass screen UVA rays to prevent eye injuries and use sunscreen to avoid sunburn.
- A warm up session to skiing including flexibility exercises joint. The intensity of physical exertion during progressive skiing is heated while the joints in the early downs.
- Ski slopes on the evolution of other skiers to avoid collisions.
- Let the physical activity to note the first signs of fatigue.
- Rest enough. In case of injury at the last minute of the day, may be due to fatigue or by lack of sleep or excessive physical activity.
On the other hand, emphasized that the most common injuries suffered by skiers often the vertebral column, although the percentage of suffering a serious injury is very low. The upper extremities were also affected in the fall, while snowboarders suffer three times more likely than skiers. In this regard emphasize that children are the ones who suffer the most, reaching reach 79% of total injuries.
Another of the most characteristic lesions of skiers is the sprained thumb from ruptured ligaments. Is presented in 7-10% of those who practiced this sport, and occurs in a fall on the hand with a clenched fist holding a stick.
However, the lower end is where the majority of ski injuries, and frequent fractures of the tuberosity of the talus in the case of the practitioners of snowboarding and downhill skiing, the medial ligament sprain or injury the same in its proximal insertion (point of skiing), along with fractures of the tibia, are the most common.
Wednesday, February 11, 2009
Pharmaceutical research will increase the investment
Removed at the end of December the Ministry of Health regulations and other reforms with the new Clinical Research in the period 2009-2010 the amount of annual investment for drug research, 100 million dollars per year is estimated to be over.
Researchers in the Pharmaceutical Companies Association (AİFD) according to the study, the majority of diseases including cancer, 7 thousand 500 new products in the world pharmaceutical market research takes over.
In this study, a molecule of the drug into clinical research for 10-15 years, Turkey's medical, scientific and economic development by contributing to the scientific environment will ensure more effective representation was given to the prediction.
Turkey's clinical research has the potential to draw attention, while on this issue the necessary arrangements, as well as enthusiastic and experienced researchers, international recognition and accreditation of research centers, and patients with the potential addition of the state, as well as pharmaceutical industry nün be willing to invest the saved.
-TURKEY, ISRAEL AND COUNTRIES LIKE GREECE BACK in -
According to the study, despite all this potential, the number of clinical research in terms of Turkey's population is much lower than Israel, even in countries such as Greece and Switzerland are in the back.
Accordingly, last year in Germany with a population of 83 million 4 thousand 364, with a population of 64 million 3 thousand 752 in France, 60 million people in the UK with 3 bin 207, with 58 million population in Italy 2 bin 406, with 43 million population of Spain ' or 2 thousand 98 thousand 307 in Poland with 39 million inhabitants, 144 million population and 951 clinical research done in Russia.
2 thousand in Israel with a population 7'şer to 780 million, 441 thousand in Switzerland, with 11 million population in Greece and 560 are carried out clinical research, clinical research in Turkey, only 462 were made.
Clinical research, designated as a national policy of strategic areas to be in the running, as compatible with EU directives out of the new regulations, drug development in the country open to competition all over the world can point to.
- $ 100 million of''BULUR'' -
Merck Sharp Dohme Pharmaceuticals for Health Policy, Access, and Director of Corporate Communications Jeffrey Kemprecos, despite adverse conditions, in 2008 in Turkey, the clinical research of innovative pharmaceutical industry has increased at a rate of 30-40 percent.
That's it in a short time to experience such an increase, biotechnology and pharmaceutical industry researchers nün aware of Turkey's potential is there, and even investments in Turkey has started to shift is an indication striking Kemprecos, said:
Very eager''to do clinical research, have placed many hospitals, universities and found a doctor, but, like Greece or Israel, from Turkey to the much smaller amount of investment and research in countries on the number of cases are not reached yet. However, the Regulation of Clinical Research to be removed as we see a big improvement. Current trends continue, the number of clinical research in Turkey may be a short time later to Greece and even 2 times more clinical research may be competitors in Russia are made.''
Merck Sharp in 2008 in Turkey Dohme'un realized that increasing the number of clinical research, this issue seriously in the year 2009 have announced plans to increase the Kemprecos in the direction that has continued as follows:
Clinical research in Turkey, clinicians and institutions''to currently about 40 million dollars per year in the amount of funds are transferred. New clinical research regulations and other reforms in the amount of annual investment in the period 2009-2010, 100 million dollars per year are estimated to be over.''
-''ECONOMIC CRISIS ETKİLEMEZ'' -
Global economic crisis, even though R & D investment continues to be expected, drug companies invest in this type of disclaimer that the opinions expressed in the Kemprecos,''in this area increased Turkish medicine and science to the world will be a support, such as voluntary patients, the development stage promising new treatment methods that can provide controlled access''I was talking.
In 2009 this field will be a turning point indicating Kemprecos,''Turkey's hospitals, universities and human capital issues such as the advantages of having taken into consideration, the private sector, innovative drug development nün that a rapid response is observed to be''
Researchers in the Pharmaceutical Companies Association (AİFD) according to the study, the majority of diseases including cancer, 7 thousand 500 new products in the world pharmaceutical market research takes over.
In this study, a molecule of the drug into clinical research for 10-15 years, Turkey's medical, scientific and economic development by contributing to the scientific environment will ensure more effective representation was given to the prediction.
Turkey's clinical research has the potential to draw attention, while on this issue the necessary arrangements, as well as enthusiastic and experienced researchers, international recognition and accreditation of research centers, and patients with the potential addition of the state, as well as pharmaceutical industry nün be willing to invest the saved.
-TURKEY, ISRAEL AND COUNTRIES LIKE GREECE BACK in -
According to the study, despite all this potential, the number of clinical research in terms of Turkey's population is much lower than Israel, even in countries such as Greece and Switzerland are in the back.
Accordingly, last year in Germany with a population of 83 million 4 thousand 364, with a population of 64 million 3 thousand 752 in France, 60 million people in the UK with 3 bin 207, with 58 million population in Italy 2 bin 406, with 43 million population of Spain ' or 2 thousand 98 thousand 307 in Poland with 39 million inhabitants, 144 million population and 951 clinical research done in Russia.
2 thousand in Israel with a population 7'şer to 780 million, 441 thousand in Switzerland, with 11 million population in Greece and 560 are carried out clinical research, clinical research in Turkey, only 462 were made.
Clinical research, designated as a national policy of strategic areas to be in the running, as compatible with EU directives out of the new regulations, drug development in the country open to competition all over the world can point to.
- $ 100 million of''BULUR'' -
Merck Sharp Dohme Pharmaceuticals for Health Policy, Access, and Director of Corporate Communications Jeffrey Kemprecos, despite adverse conditions, in 2008 in Turkey, the clinical research of innovative pharmaceutical industry has increased at a rate of 30-40 percent.
That's it in a short time to experience such an increase, biotechnology and pharmaceutical industry researchers nün aware of Turkey's potential is there, and even investments in Turkey has started to shift is an indication striking Kemprecos, said:
Very eager''to do clinical research, have placed many hospitals, universities and found a doctor, but, like Greece or Israel, from Turkey to the much smaller amount of investment and research in countries on the number of cases are not reached yet. However, the Regulation of Clinical Research to be removed as we see a big improvement. Current trends continue, the number of clinical research in Turkey may be a short time later to Greece and even 2 times more clinical research may be competitors in Russia are made.''
Merck Sharp in 2008 in Turkey Dohme'un realized that increasing the number of clinical research, this issue seriously in the year 2009 have announced plans to increase the Kemprecos in the direction that has continued as follows:
Clinical research in Turkey, clinicians and institutions''to currently about 40 million dollars per year in the amount of funds are transferred. New clinical research regulations and other reforms in the amount of annual investment in the period 2009-2010, 100 million dollars per year are estimated to be over.''
-''ECONOMIC CRISIS ETKİLEMEZ'' -
Global economic crisis, even though R & D investment continues to be expected, drug companies invest in this type of disclaimer that the opinions expressed in the Kemprecos,''in this area increased Turkish medicine and science to the world will be a support, such as voluntary patients, the development stage promising new treatment methods that can provide controlled access''I was talking.
In 2009 this field will be a turning point indicating Kemprecos,''Turkey's hospitals, universities and human capital issues such as the advantages of having taken into consideration, the private sector, innovative drug development nün that a rapid response is observed to be''
"Private medical centers to merge"
Fatma Ergüzeloğlu / Ankara
Social Security Institution (SGK) General Health Insurance Deputy General Manager Dr. Sami Turkoglu, pharmacists can close the shutter, but it may give drug to reach the citizens of the state of the drug can legally make changes, he said. Türkoğlu, "Pharmacists in the 'I is not that close to shutter' approach has to shut down, not medicine, but also citizens of the state of the drug to reach the law changes, including what you need to do, because it's the task is." Şeklinde spoke.
Detached Industrialists' and Businessmen's Association (MÜSİAD) organized by the health sector on the future of nude panel, and the Ministry of Health was held in Ankara with the participation of SGK officials.
Deputy General Manager of General Health Insurance Dr SGK. Sami Turkoglu, the institution's medical expenses in the year made a presentation describing. Turkoglu's presentation set the stage for discussion from time to time had a glow. Minister of Health to take place in the program, but Health Minister Recep Akdag and did not attend the meeting, Undersecretary Nihat Tosun.
Yeşilyurt: Medical centers to merge
Assistant Undersecretary of the Ministry of Health Rights Yeşilyurt participants answered the questions. Yeşilyurt speech, the private sector, 30 percent of the difference-70 percent of wages, and that opinion in the direction of the Minister of 75'lere to withdraw their comments, which is the subject, the final decision will be announced in the next day, he said.
Indicating that the limited human resources Yeşilyurt, "4 At the moment working with the specialist medical center wants diversity, combined with a medical center in a building a stronger independent medical center are open, our legislation permitting it. Can also return to the hospital. Additional human resources demand not just from us, "he spoke.
Speech often interrupted Türkoğlu, "all payments of around 40 percent in a country where the drug or drugs may be a situation such as a pharmacist did you not care about? Pharmacist-pharmacist partnerships in this area is called, but the Ministry of Health is not a study. Our aim in the negotiations to agree with the pharmacist. We did not see such a thing from the hospital until today. We have 25 thousand pharmaceutical sector from 250-500 thousand people who eat bread there, they all accept, but the population of 72 million have taken the medicine we have. We have resources and we need certain. We will reconcile. Is only about obstructive advance, "he spoke.
"Examination fees charged to private"
Contributions from pharmacies to pay fees to be introduced in response to criticism Türkoğlu example, "Examination of the participation share of the sample, Okmeydani, Adana State Hospital have the opportunity you get?" She said to the Deputy Undersecretary of Rights Yeşilyurt left. Yeşilyurt the question, "We collect money for hospitals have completely removed. But the private hospitals can have this opportunity "as answered. Turkoglu, the Turkish Pharmacists Association (TEB) 's examination of the contribution collected from pharmacies, but to oppose, without the application of many pharmacists took to be extremely happy. "Examination of the participation share of the pharmacy is charged on October 1 is not an application has been invented. This application is in progress since 2004-2005, "he Türkoğlu speaking, only the numbers have been changed, and actively working as a TL 10-6-4-3 with spouses and children has been charged, has been cut from the system of retirement.
The only price co -
30 percent difference in fees to be removed to limit defensive MÜSİAD Healthcare Committee Chairman Dr. Loyal Consultants, said it must be hard to control.
Private health sector of employment nün doctors and hospitals, in addition to advanced technological medical devices connected to the Ministry such as permit applications should be canceled or that the Consultant, the complete sector of the health facilities they are planning to join a license was requested.
Loyal Consultants, the health system by drawing attention to the rapid changes in the sector must be taken to secure the services of recruitment said.
"SGK appeal against cuts in their total bill payments are postponed. This application should only stop the payment is subject to appeal. "Speaking as Consultant, payments must be in the specified time period was recorded.
Indicating they support the co-advisor, public and private health sector by eliminating the difference between the contribution share has to be done 5 TL.
Regional pricing to be passed in SUT
Consultant pharmacists in public institutions in favor of discounts that improvements must be made with the Pharmacy Act of pharmacist-pharmacist partnerships to prevent the return of the chain pharmacies point was to make arrangements. In talking to these recommendations were given:
"Pharmacists and once stocks of amnesty should be brought, SGK with agreements the parties' agreement, according to the need renewal, oral and dental health services system in should be taken; 20 thousand dentists in the 14 thousand-handed practices of the contract covered should, technical specifications and standards should be brought, some health services Health Practice Tebliği (SUT) prices costs remain under the issue should be resolved, milk prices regional pricing to be passed, doctors and auxiliary medical personnel open quickly in the plan should be corrected, universities quotas should be increased, doctors compulsory service and is considered full-time law plus and minus again be assessed, in a hospital medical director and should be passed to the director of business, branch-branch in the region required the establishment of hospitals in the private health sector should be encouraged. "
Special to the classification is how you look at?
Private hospitals, the Ministry of Health hospitals in the classification plan, the difference in wages and 100 percent higher was supported by the record. Examination fee to be 5 lira demand special hospitals, because of these charges and this will lead to patients' health will improve also suggest drug expenses are
Fatma Ergüzeloğlu / Ankara
Ministry of Health hospitals, which supports the work categories Association of Private Hospitals and Health Foundation (OHSAD), Ministry of health service providers to put their own arrangements to avoid disputes between them should be reported.
Private health institutions to undertake the cost of the license by specifying serious stage, a series of personnel and infrastructure to meet the standard because of the operation of the institution "also be punished" have been saved.
OHSAD additional fee was requested on the integration of flexible boundaries. At a rate of 100 per cent of all private institutions Licensed difference is recommended to take charge, the quality criteria that meet a certain percentage of institutions have come out on top of this there has been expressed.
Social Security Institution (SGK) OHSAD delegation with representatives from a private health institutions will be signed between SGK and Purchase Agreement relating to Health Service has recommended.
HEALTH CENTER, DRUG COSTS improves "
OHSAD current application and the number of prescription drug costs in the long term will improve short-said. According to World Health Organization report, 1 written prescriptions and medicines in health institutions basamak s 2nd due to the same disease group health institutions of digits written that the drug is higher than machines OHSAD, examination of patients from hospitals because of the cost of participation will lead to health and this also improves the drug costs were expressed. The most important reason for working in the health of the general practitioners, specialist physicians based on the type of prescription drugs to more focused and does not have infection, despite the widespread use of antibiotics has been shown to prefer.
"INSPECTION CONTRACT PAY 5 TL OLMALI"
Between the request message to the first row SGK'ya participation rate was examined. The patients go to private health institutions from 10 TL U.S. examination of the cost of participation, the public hospitals to compete unfairly against the private sector, dragging the bodies of patients and it was stated that the victim is reduced to the state. General Health Insurance Act, the examination of the cost of participation 1, 2 and 3 health service providers at different levels according to the steps may be identified, but among the public and private health server can not be any discrimination, it is illegal to take it forward.
Examination of the public and private sector participation fee equal to demand implementation OHSAD, has requested not to exceed fee of 5 USD. Participation will be taken for examination and medical examination of the purchase price as may be specified under the two-stage sample were as follows:
"For example, examinations for 3 TL, 3 TL for prescription drugs and by 2 stages (3 + 3) collection can be done. In this case, treatment and drug costs in the total level of savings can be 20-30 percent. High-cost private institutions participating in the private sector only cause patients to reduce the public hospitals and public health institutions, especially in primary care leads to a serious increase in patients.
"CRIMINAL be LOWER AMOUNT"
OHSAD, SGK Services Agreement for Purchase order changes are suggestions. Additional charges against more than to get private health institutions getirilen should reduce the amount of penalties that the Association to contract more serious acts of infringement that host is taken into consideration will be given 10 thousand TL in the penalty must not exceed said. In more than one violation of the act in the case of patients for each billing period is only one sentence has been proposed. Received more than 5 times the amount established in the direction of the penalty will be prepared to give substance to the provisions of the contract was requested inclusion.
The agreed area, to establish additional fees to be notified within 5 days of editing changes that need to be revised provisions also specified. , Noted that "in 2009 by the Council of Ministers and institutions likely be made aware of rate changes to the contract to be released 01 January 2009 by reason of special centers to implement this Article and the revised text should be possible to adapt to changes" was said. However, the agreed areas, health authorities will be given by "the document indicates additional charges" relating to the provisions of regulations should be re-phrase that has been open.
"Branches of CANCEL CANCEL arrangements should be brought"
The physician within 60 days instead of leaving to work does not start a new physician, industry and other applications, organizer, cancellation of the contract clause of the revision was requested. Association brought the following recommendation:
"This section is in contradiction with the legislation and health and includes statements beyond the purpose. Because the Ministry of Health in such cases and that the industry does not cancel in the application does not want to. Moreover, because doctors can not find the same item to be removed from the registration of branches in the 60-day period is used, as not all branches of industry not only are doctors not try to make it, so the hospital closes. This section should be removed from the text. "
" 'PART-TIME" LIMIT OF PATIENTS physician must "
OHSAD, physicians can provide more efficient services outside regular doctor "part-time" needs to see the doctor and the patient quota limit must be reported. "Or, actually," part-time "to doctors working in private institutions is not allowed to say, this new regulation from the private hospitals will be available to part-time physicians have used enough of the right to be mean to take forward. In addition, 50 patients daily or monthly limit of 350 weeks as the implementation of 1500 patients will increase the efficiency has been defended.
"Non-physician health personnel" described by the circular opening of the medical officer, nurse, etc.. should be as clearly specified. Of Physiotherapy technician (physiotherapist) to work under the supervision of health personnel allow 3 to help was requested.
Agreement "founding partner" phrase be removed from the text was. "Founding partners, the respective companies even if they transfer all the shares in the company of the newspaper are always available as a founding partner. This statement is technically impossible because of the center is like the application "was said.
"PROCEDURE TO PARTNER must be addressed"
Health agencies in the partnership to change the changes are published in the Trade Registry of the newspaper article also criticized the contract stipulate that the Association has the following suggestions:
"Trade Register, etc. changes the transfer of shares in the newspaper in the newspaper is registered, but registration of the respective companies to reach the newspaper often takes several months. Therefore, removing the 30-day period should be at least 6 months. Moreover, companies often are not any changes ünvanlarında does not require license changes. Therefore, the above paragraph should look like this: Health services server owner and joint-stock company in the management board members and / or founding partners, other types of companies in the public all or a portion to be modified, if this change register gazetesinde release from 6 months to dry to report and the necessary documents is obliged to transmit. Dry the notice by the Ministry of Health on behalf of the person who inherits the ruhsatname / activity permit to change if necessary until a new license arrangement, health service providers to the former owner and managing director in charge of the activity continues. In the event of detection of timely notice, this contract (5.1.10) is done according to Article no'lu. "
"Package price must be at the Mağduriyetleri EXPENSES"
Package the applications for examinations, treatment, medication and blood products, such as spending more than 50 percent of package price to prevent victimization in the direction of the cases were brought following recommendations:
"Additional-9 in the list of the package during operation the examination and analysis used in medical materials, blood, blood products and drugs of the cost of total package price of 1 / 2 'sini if exceeded, medical and administrative reasons, by specifying and documenting the institution to be accepted on condition that 1 / 2 URL beyond the part is also paid. These types of cases, 'other' by using the buttons must be billed separately. Pricing adopted by the Agency will apply the official prices. "
"CRIMINAL TO BRING acts which must be"
Failure by the blood from the center of the penalty foreseen in the "emergency situation and medical requirements" should not apply in the case were recorded. Fines of a portion of which acts sehven, a section of code and system error occurred in a section may also be required to specify clearly the definition of this case has been requested.
Nevertheless, violations of criminal procedure require termination of the contract and the related first defense to be taken and the contract may be suspended certain period were to be rearranged. And deliberate acts always made sehven request was made to distinguish. OHSAD has suggested the following:
"Many hospitals in each billing period averaged over 15-thousand-20 thousand MEDULA are different modes of operation and 0.1 percent (in thousands 1) process error means error even 15-20. Likewise, the quality of services and services that are used to prove documents, hospitals and programs MEDULA problems, frequent change of the SUT and attachments, and all this code in the computer and the internet this kind inevitably makes mistakes sometimes. In fact, the termination process will be is not easy to identify as indisputable. Between the center of the contract because of this Article institutions will be replaced in case of serious disputes or at least the previous version needs to be protected. "
SUGGESTIONS FOR getirilen SUT
To avoid unnecessary delays pre-payment must be made that the appeal OHSAD, agreed by the Authority before the center to have a chance to complete the requested documents were requested. For this purpose, the application Tebliği Health (SUT) 'What has been proposed to add the following paragraph:
"Except to the invoice, billed as an attachment to the lack of all the documents at the request of the institution may be resolved by the relevant centers. For this, corresponding to the center before the bill agreed on MEDULA excluding other documents in the appendix can be returned to the contracted health facilities, and 3 days to complete the correction period is known. "
WORK INTERRUPTION YAPAN SGK deliberately CRIMINAL
Review of appeals made to interfere with the results of the industry's only objection was to stop payments. Some provinces are all stopped up with payment by the hospital "What appeals to all branches except the branch must be paid or 90 percent of the total invoice amount must be paid" was said. Agency employees who willfully cuts implementation issue was brought to punishment. System can not be given back or MEDULA given as invoices can be manually determined by the medical material of equivalent criteria, the equivalent of creating the list was requested.
Fatma Ergüzeloğlu / Ankara
Ministry of Health hospitals, which supports the work categories Association of Private Hospitals and Health Foundation (OHSAD), Ministry of health service providers to put their own arrangements to avoid disputes between them should be reported.
Private health institutions to undertake the cost of the license by specifying serious stage, a series of personnel and infrastructure to meet the standard because of the operation of the institution "also be punished" have been saved.
OHSAD additional fee was requested on the integration of flexible boundaries. At a rate of 100 per cent of all private institutions Licensed difference is recommended to take charge, the quality criteria that meet a certain percentage of institutions have come out on top of this there has been expressed.
Social Security Institution (SGK) OHSAD delegation with representatives from a private health institutions will be signed between SGK and Purchase Agreement relating to Health Service has recommended.
HEALTH CENTER, DRUG COSTS improves "
OHSAD current application and the number of prescription drug costs in the long term will improve short-said. According to World Health Organization report, 1 written prescriptions and medicines in health institutions basamak s 2nd due to the same disease group health institutions of digits written that the drug is higher than machines OHSAD, examination of patients from hospitals because of the cost of participation will lead to health and this also improves the drug costs were expressed. The most important reason for working in the health of the general practitioners, specialist physicians based on the type of prescription drugs to more focused and does not have infection, despite the widespread use of antibiotics has been shown to prefer.
"INSPECTION CONTRACT PAY 5 TL OLMALI"
Between the request message to the first row SGK'ya participation rate was examined. The patients go to private health institutions from 10 TL U.S. examination of the cost of participation, the public hospitals to compete unfairly against the private sector, dragging the bodies of patients and it was stated that the victim is reduced to the state. General Health Insurance Act, the examination of the cost of participation 1, 2 and 3 health service providers at different levels according to the steps may be identified, but among the public and private health server can not be any discrimination, it is illegal to take it forward.
Examination of the public and private sector participation fee equal to demand implementation OHSAD, has requested not to exceed fee of 5 USD. Participation will be taken for examination and medical examination of the purchase price as may be specified under the two-stage sample were as follows:
"For example, examinations for 3 TL, 3 TL for prescription drugs and by 2 stages (3 + 3) collection can be done. In this case, treatment and drug costs in the total level of savings can be 20-30 percent. High-cost private institutions participating in the private sector only cause patients to reduce the public hospitals and public health institutions, especially in primary care leads to a serious increase in patients.
"CRIMINAL be LOWER AMOUNT"
OHSAD, SGK Services Agreement for Purchase order changes are suggestions. Additional charges against more than to get private health institutions getirilen should reduce the amount of penalties that the Association to contract more serious acts of infringement that host is taken into consideration will be given 10 thousand TL in the penalty must not exceed said. In more than one violation of the act in the case of patients for each billing period is only one sentence has been proposed. Received more than 5 times the amount established in the direction of the penalty will be prepared to give substance to the provisions of the contract was requested inclusion.
The agreed area, to establish additional fees to be notified within 5 days of editing changes that need to be revised provisions also specified. , Noted that "in 2009 by the Council of Ministers and institutions likely be made aware of rate changes to the contract to be released 01 January 2009 by reason of special centers to implement this Article and the revised text should be possible to adapt to changes" was said. However, the agreed areas, health authorities will be given by "the document indicates additional charges" relating to the provisions of regulations should be re-phrase that has been open.
"Branches of CANCEL CANCEL arrangements should be brought"
The physician within 60 days instead of leaving to work does not start a new physician, industry and other applications, organizer, cancellation of the contract clause of the revision was requested. Association brought the following recommendation:
"This section is in contradiction with the legislation and health and includes statements beyond the purpose. Because the Ministry of Health in such cases and that the industry does not cancel in the application does not want to. Moreover, because doctors can not find the same item to be removed from the registration of branches in the 60-day period is used, as not all branches of industry not only are doctors not try to make it, so the hospital closes. This section should be removed from the text. "
" 'PART-TIME" LIMIT OF PATIENTS physician must "
OHSAD, physicians can provide more efficient services outside regular doctor "part-time" needs to see the doctor and the patient quota limit must be reported. "Or, actually," part-time "to doctors working in private institutions is not allowed to say, this new regulation from the private hospitals will be available to part-time physicians have used enough of the right to be mean to take forward. In addition, 50 patients daily or monthly limit of 350 weeks as the implementation of 1500 patients will increase the efficiency has been defended.
"Non-physician health personnel" described by the circular opening of the medical officer, nurse, etc.. should be as clearly specified. Of Physiotherapy technician (physiotherapist) to work under the supervision of health personnel allow 3 to help was requested.
Agreement "founding partner" phrase be removed from the text was. "Founding partners, the respective companies even if they transfer all the shares in the company of the newspaper are always available as a founding partner. This statement is technically impossible because of the center is like the application "was said.
"PROCEDURE TO PARTNER must be addressed"
Health agencies in the partnership to change the changes are published in the Trade Registry of the newspaper article also criticized the contract stipulate that the Association has the following suggestions:
"Trade Register, etc. changes the transfer of shares in the newspaper in the newspaper is registered, but registration of the respective companies to reach the newspaper often takes several months. Therefore, removing the 30-day period should be at least 6 months. Moreover, companies often are not any changes ünvanlarında does not require license changes. Therefore, the above paragraph should look like this: Health services server owner and joint-stock company in the management board members and / or founding partners, other types of companies in the public all or a portion to be modified, if this change register gazetesinde release from 6 months to dry to report and the necessary documents is obliged to transmit. Dry the notice by the Ministry of Health on behalf of the person who inherits the ruhsatname / activity permit to change if necessary until a new license arrangement, health service providers to the former owner and managing director in charge of the activity continues. In the event of detection of timely notice, this contract (5.1.10) is done according to Article no'lu. "
"Package price must be at the Mağduriyetleri EXPENSES"
Package the applications for examinations, treatment, medication and blood products, such as spending more than 50 percent of package price to prevent victimization in the direction of the cases were brought following recommendations:
"Additional-9 in the list of the package during operation the examination and analysis used in medical materials, blood, blood products and drugs of the cost of total package price of 1 / 2 'sini if exceeded, medical and administrative reasons, by specifying and documenting the institution to be accepted on condition that 1 / 2 URL beyond the part is also paid. These types of cases, 'other' by using the buttons must be billed separately. Pricing adopted by the Agency will apply the official prices. "
"CRIMINAL TO BRING acts which must be"
Failure by the blood from the center of the penalty foreseen in the "emergency situation and medical requirements" should not apply in the case were recorded. Fines of a portion of which acts sehven, a section of code and system error occurred in a section may also be required to specify clearly the definition of this case has been requested.
Nevertheless, violations of criminal procedure require termination of the contract and the related first defense to be taken and the contract may be suspended certain period were to be rearranged. And deliberate acts always made sehven request was made to distinguish. OHSAD has suggested the following:
"Many hospitals in each billing period averaged over 15-thousand-20 thousand MEDULA are different modes of operation and 0.1 percent (in thousands 1) process error means error even 15-20. Likewise, the quality of services and services that are used to prove documents, hospitals and programs MEDULA problems, frequent change of the SUT and attachments, and all this code in the computer and the internet this kind inevitably makes mistakes sometimes. In fact, the termination process will be is not easy to identify as indisputable. Between the center of the contract because of this Article institutions will be replaced in case of serious disputes or at least the previous version needs to be protected. "
SUGGESTIONS FOR getirilen SUT
To avoid unnecessary delays pre-payment must be made that the appeal OHSAD, agreed by the Authority before the center to have a chance to complete the requested documents were requested. For this purpose, the application Tebliği Health (SUT) 'What has been proposed to add the following paragraph:
"Except to the invoice, billed as an attachment to the lack of all the documents at the request of the institution may be resolved by the relevant centers. For this, corresponding to the center before the bill agreed on MEDULA excluding other documents in the appendix can be returned to the contracted health facilities, and 3 days to complete the correction period is known. "
WORK INTERRUPTION YAPAN SGK deliberately CRIMINAL
Review of appeals made to interfere with the results of the industry's only objection was to stop payments. Some provinces are all stopped up with payment by the hospital "What appeals to all branches except the branch must be paid or 90 percent of the total invoice amount must be paid" was said. Agency employees who willfully cuts implementation issue was brought to punishment. System can not be given back or MEDULA given as invoices can be manually determined by the medical material of equivalent criteria, the equivalent of creating the list was requested.
Crisis, the pharmaceutical industry has identified the target
Until the year 2012 total 300 million U.S. dollars export target is, but this target due to the crisis has been identified indicating Mustafa Nevzat Drug Industry General Manager Levent Selamoğlu, "the crisis would be that way to go we hope. But in 2012 he no longer went to 2015." he said.
Mustafa Nevzat Drug Industry General Manager Selamoğlu, affected by global economic crisis, the most common cause of major cost increases that were expressed. Turkey's pharmaceutical industry in general is similar to the pharmaceutical industry in the world to live in Turkey and a table of the imported drugs are a significant part hammaddesinin that point Selamoğlu, that the cost of imported inputs increased pressure on the exchange is made.
COST ART was not performed PRICE REGULATION
Within the past year, increasing electricity and natural gas fiyatlarınında themselves severely affected by Selamoğlu said, "Labor costs also has increased. All this we have put on top when the last quarter of the year in Turkey, especially in the pharmaceutical industry production in the company average of around 25-30 per cent cost The increase in cases was. This made the cost of medicines in Turkey by the government determined prices for the drugs did not increase at all in the posture. Therefore, at this time of the Turkish pharmaceutical industry, a serious increase in costs faced. But no price regulation have been made. It's long-term Turkish pharmaceutical industry will be seriously affected. hope that the government, the Ministry of Health and Ministry of Finance to take necessary measures related to the implementation of the current price regulation in Turkey will make an arrangement with the pharmaceutical price "as it had not.
Crisis of the world pharmaceutical industry what the impact assessed Levent Selamoğlu, "the world of the pharmaceutical companies as a serious cost has increased. This increase in cost, depending on who they are working on positioning. Özellikle use financing for the company a serious interest or pressure to find funding pressures have . All this, in general negative affect factors. But once there is a positive situation, in this crisis in drug demand is not narrowing. Ilac In this sense, immune to attack an industry. People get ill when you attack or not to take medication in case. In this sense, in other industries As no contraction in demand, "he said.
Mustafa Nevzat Pharmaceuticals in 2007's America started exporting a product that reminds Selamoğlu, in June 2008 in the second product into the market and now are waiting for a third of the product made out of license. 2009 in the third, fourth or maybe fifth of products into the U.S. market will be Selamoğlu expression, "the American market for the foreseeable a sales chart was fast, but slowly rising steadily ... O framework currently our exports continues. Hopefully, this crisis from the I look will not be affected. We did not see much of an impact it, "he said.
Company in 2008 as a live negativity, even in the last quarter started with the crisis, the negative impact felt more strongly started to tell Levent Selamoğlu, in 2008 the budget to keep the target was close, but from September 2008 since the 2009 budget to create söyledi. Selamoğlu, 2008 turnover of 180 million dollars was added to the word.
SOME INVESTMENTS Suspended
Increasing cost pressures, price increases and the establishment such as the uncertainty of the year 2009 for a numerical target is difficult to tell that Selamoğlu recording said: "(for 2009) 100 TL U.S. Our scenario also has 10 TL line our scenario and that a broad range look. 2009 than previously planned investment had, I currently have suspended. Plant additional production space to add our projects are in condition has stopped. Şekerpınar'da got a plant, it has been considered for a project had it suspended status are. 2009 about investment in the current conditions, only the essential, very urgent to do, things have limits. But conditions change, the economic environment in Turkey goes to the better if the existing projects will revive. 2009 in the United States than three of our products to enter into hope. but in addition to the 28 countries we We are exporting. this country is the number of 35'e are planning to remove. Current on it are working. Germany is very high in our exports there, there's enlargement bekliyoruz. England would enter the market in 2009 in. Yurt is a new year just two new products were launched on the market. Year until the end of the probably 8 to 10 around the product to market we'll think. 2009 in the circuit will enter into a new factory have; Investment in 2007 began, was completed in 2008. Current pilot production finished. ready for commercial production has become. Cancer products will produce a plant. In 2009 the cancer products will begin to sell in both Turkish and world markets. The 25 million dollar investment. "
YEAR 2012, went ARTIK 2015
Until the year 2012 total 300 million U.S. dollars export target is, but this target due to the crisis has been identified indicating Mustafa Nevzat Drug Industry General Manager Levent Selamoğlu, "the crisis would be that way to go we hope. But in 2012 he no longer went to 2015." he said.
Turkish pharmaceutical sector, especially the price nün serious about the expectation that indicates Selamoğlu, "for myself I would say, the Indian government or the government of Poland, Hungary's government, China's government on its own pharmaceutical industry is how you look at it, we of the Turkish government in the Turkish pharmaceutical industry, especially in Turkey production of the company so we want to look. look extremely careful that we know, but we have enough understanding and enough that we do not believe reviews. So the Turkish pharmaceutical industry production technology and capacity to host the human resources in Turkey today and how a large automotive exports has been the means of the same drug things may happen. So we not only spend money that occasion as an industry not to earn the money, countries can provide an input as an industry need to see the government. Görenler are absolutely, is our fault necessarily. So that we ourselves enough but expressed a view that the Turkish pharmaceutical industry, exporting to, R & D can do its own drug molecules discovered and developed in one direction may bring. " he said.
R & D to have SERIOUS INVESTMENT
In Turkey, R & D investment is not just the past year being the R & D Act, together with a serious future developments can be expressed as the Selamoğlu, "company as R & D means a serious investment we have. At the moment our staff close to 40 R & D from running. TÜBİTAK and universities are doing joint projects. In this sense, future studies are serious. " he said.
We are not against foreign partners to
Selamoğlu 100 percent of local companies to foreign partners by how they look is on the question, "Foreign partners are not against. Domestic partners also are not met. But the partnership, or business units to bring an added value should be. We will create added value, all business units are ready to . " gave the answer.
Levent also expressed think Selamoğlu public offerings, "indicates that we do not know what the future requirements, but current conditions is not already public offering, a method very attractive." he said.
Mustafa Nevzat Drug Industry General Manager Selamoğlu, affected by global economic crisis, the most common cause of major cost increases that were expressed. Turkey's pharmaceutical industry in general is similar to the pharmaceutical industry in the world to live in Turkey and a table of the imported drugs are a significant part hammaddesinin that point Selamoğlu, that the cost of imported inputs increased pressure on the exchange is made.
COST ART was not performed PRICE REGULATION
Within the past year, increasing electricity and natural gas fiyatlarınında themselves severely affected by Selamoğlu said, "Labor costs also has increased. All this we have put on top when the last quarter of the year in Turkey, especially in the pharmaceutical industry production in the company average of around 25-30 per cent cost The increase in cases was. This made the cost of medicines in Turkey by the government determined prices for the drugs did not increase at all in the posture. Therefore, at this time of the Turkish pharmaceutical industry, a serious increase in costs faced. But no price regulation have been made. It's long-term Turkish pharmaceutical industry will be seriously affected. hope that the government, the Ministry of Health and Ministry of Finance to take necessary measures related to the implementation of the current price regulation in Turkey will make an arrangement with the pharmaceutical price "as it had not.
Crisis of the world pharmaceutical industry what the impact assessed Levent Selamoğlu, "the world of the pharmaceutical companies as a serious cost has increased. This increase in cost, depending on who they are working on positioning. Özellikle use financing for the company a serious interest or pressure to find funding pressures have . All this, in general negative affect factors. But once there is a positive situation, in this crisis in drug demand is not narrowing. Ilac In this sense, immune to attack an industry. People get ill when you attack or not to take medication in case. In this sense, in other industries As no contraction in demand, "he said.
Mustafa Nevzat Pharmaceuticals in 2007's America started exporting a product that reminds Selamoğlu, in June 2008 in the second product into the market and now are waiting for a third of the product made out of license. 2009 in the third, fourth or maybe fifth of products into the U.S. market will be Selamoğlu expression, "the American market for the foreseeable a sales chart was fast, but slowly rising steadily ... O framework currently our exports continues. Hopefully, this crisis from the I look will not be affected. We did not see much of an impact it, "he said.
Company in 2008 as a live negativity, even in the last quarter started with the crisis, the negative impact felt more strongly started to tell Levent Selamoğlu, in 2008 the budget to keep the target was close, but from September 2008 since the 2009 budget to create söyledi. Selamoğlu, 2008 turnover of 180 million dollars was added to the word.
SOME INVESTMENTS Suspended
Increasing cost pressures, price increases and the establishment such as the uncertainty of the year 2009 for a numerical target is difficult to tell that Selamoğlu recording said: "(for 2009) 100 TL U.S. Our scenario also has 10 TL line our scenario and that a broad range look. 2009 than previously planned investment had, I currently have suspended. Plant additional production space to add our projects are in condition has stopped. Şekerpınar'da got a plant, it has been considered for a project had it suspended status are. 2009 about investment in the current conditions, only the essential, very urgent to do, things have limits. But conditions change, the economic environment in Turkey goes to the better if the existing projects will revive. 2009 in the United States than three of our products to enter into hope. but in addition to the 28 countries we We are exporting. this country is the number of 35'e are planning to remove. Current on it are working. Germany is very high in our exports there, there's enlargement bekliyoruz. England would enter the market in 2009 in. Yurt is a new year just two new products were launched on the market. Year until the end of the probably 8 to 10 around the product to market we'll think. 2009 in the circuit will enter into a new factory have; Investment in 2007 began, was completed in 2008. Current pilot production finished. ready for commercial production has become. Cancer products will produce a plant. In 2009 the cancer products will begin to sell in both Turkish and world markets. The 25 million dollar investment. "
YEAR 2012, went ARTIK 2015
Until the year 2012 total 300 million U.S. dollars export target is, but this target due to the crisis has been identified indicating Mustafa Nevzat Drug Industry General Manager Levent Selamoğlu, "the crisis would be that way to go we hope. But in 2012 he no longer went to 2015." he said.
Turkish pharmaceutical sector, especially the price nün serious about the expectation that indicates Selamoğlu, "for myself I would say, the Indian government or the government of Poland, Hungary's government, China's government on its own pharmaceutical industry is how you look at it, we of the Turkish government in the Turkish pharmaceutical industry, especially in Turkey production of the company so we want to look. look extremely careful that we know, but we have enough understanding and enough that we do not believe reviews. So the Turkish pharmaceutical industry production technology and capacity to host the human resources in Turkey today and how a large automotive exports has been the means of the same drug things may happen. So we not only spend money that occasion as an industry not to earn the money, countries can provide an input as an industry need to see the government. Görenler are absolutely, is our fault necessarily. So that we ourselves enough but expressed a view that the Turkish pharmaceutical industry, exporting to, R & D can do its own drug molecules discovered and developed in one direction may bring. " he said.
R & D to have SERIOUS INVESTMENT
In Turkey, R & D investment is not just the past year being the R & D Act, together with a serious future developments can be expressed as the Selamoğlu, "company as R & D means a serious investment we have. At the moment our staff close to 40 R & D from running. TÜBİTAK and universities are doing joint projects. In this sense, future studies are serious. " he said.
We are not against foreign partners to
Selamoğlu 100 percent of local companies to foreign partners by how they look is on the question, "Foreign partners are not against. Domestic partners also are not met. But the partnership, or business units to bring an added value should be. We will create added value, all business units are ready to . " gave the answer.
Levent also expressed think Selamoğlu public offerings, "indicates that we do not know what the future requirements, but current conditions is not already public offering, a method very attractive." he said.
TEB ERDOĞAN ÇOLAK President: "We started to lose DOMESTIC DRUG INDUSTRY"
President of Turkey Erdoğan Çolak Pharmacists Association, the domestic pharmaceutical industry has slowly started to move attention in the hands of foreigners, the $ 6 billion each year, said of the money going to foreigners.
Erdoğan Çolak, 14th in Kahramanmaras Area Chamber of Pharmacists attended the opening of the service building. Here you answer the questions of journalists When Çolak, Turkey's 36 drug producing country is one of the recall, "Sorry, world, globalization would have a trend, this trend does not want you is forced to Turkey. Turkey in the pharmaceutical industry with patent and data protection we started out . So their production is no longer a monopoly abroad have started to sell out their medicines, "he said.
Indian pharmaceutical industry's market share has fallen steadily to below Çolak recording said:
"Of course, this policy should be developed. Because the drug, a strategic product and no longer a country to country before the invasion, while the drug embargo collapse there trying to create. It is a strategic non-dependence on the very right is not an approach I think. So it's best to reduce, domestic resources are used properly and abroad this type of transfer is much reduced in a policy must be adopted as the national pharmaceutical industry and should be supported. But on this issue, unfortunately, we have here in Turkey's own policies, not yet. Foreign intervention, foreign policy, defining them as points on this issue for a rapidly We are experiencing erosion. Despite all these measures must be taken against it is. " Will be measures at the beginning of the generic drugs should be encouraged to emphasize Çolak, "rooms that in the generic drug use, and it initiated the policies that produce, rational drug use have to tell. This policy initiated and state and public authority by the support I need," he spoke.
In Turkey, the percentage share of foreign medications is based 60'lara Erdoğan Çolak emphasize, this is a very serious incident and it should be balanced in terms of domestic pharmaceutical industry has made. Çolak, "If a country we are indebted. Dış our dependence on so much, our current account deficit is too high. So here identify the correct policies and these policies to ensure spread of public authorities and health institutions as tasks are considered. We in this regard on our part, but we do more to expand and work It helps to develop the unity statement "was used.
Self-protection and research of the pharmaceutical industry is difficult to improve laboratuarlarını reminds know Çolak, universities, civil society organizations and development cooperation can be made by public authorities. Turkey's 10 billion dollars a year to take medication that brought the Çolak, 6 billion dollars of this money went to foreigners, and this situation in terms of Turkey's future status is a downturn, he said.
Erdoğan Çolak, 14th in Kahramanmaras Area Chamber of Pharmacists attended the opening of the service building. Here you answer the questions of journalists When Çolak, Turkey's 36 drug producing country is one of the recall, "Sorry, world, globalization would have a trend, this trend does not want you is forced to Turkey. Turkey in the pharmaceutical industry with patent and data protection we started out . So their production is no longer a monopoly abroad have started to sell out their medicines, "he said.
Indian pharmaceutical industry's market share has fallen steadily to below Çolak recording said:
"Of course, this policy should be developed. Because the drug, a strategic product and no longer a country to country before the invasion, while the drug embargo collapse there trying to create. It is a strategic non-dependence on the very right is not an approach I think. So it's best to reduce, domestic resources are used properly and abroad this type of transfer is much reduced in a policy must be adopted as the national pharmaceutical industry and should be supported. But on this issue, unfortunately, we have here in Turkey's own policies, not yet. Foreign intervention, foreign policy, defining them as points on this issue for a rapidly We are experiencing erosion. Despite all these measures must be taken against it is. " Will be measures at the beginning of the generic drugs should be encouraged to emphasize Çolak, "rooms that in the generic drug use, and it initiated the policies that produce, rational drug use have to tell. This policy initiated and state and public authority by the support I need," he spoke.
In Turkey, the percentage share of foreign medications is based 60'lara Erdoğan Çolak emphasize, this is a very serious incident and it should be balanced in terms of domestic pharmaceutical industry has made. Çolak, "If a country we are indebted. Dış our dependence on so much, our current account deficit is too high. So here identify the correct policies and these policies to ensure spread of public authorities and health institutions as tasks are considered. We in this regard on our part, but we do more to expand and work It helps to develop the unity statement "was used.
Self-protection and research of the pharmaceutical industry is difficult to improve laboratuarlarını reminds know Çolak, universities, civil society organizations and development cooperation can be made by public authorities. Turkey's 10 billion dollars a year to take medication that brought the Çolak, 6 billion dollars of this money went to foreigners, and this situation in terms of Turkey's future status is a downturn, he said.
Crisis and the pharmaceutical industry
New name of the crisis of capitalism, "economic crisis" happened. Domestic, foreign crisis, almost all comments, discussions, a stand-alone "financial" crisis went beyond description. Crisis no longer "economic" as an başlandı. Undoubtedly, the real estate market began to boom and banks in this financial crisis before the real sector, by itself it was not possible to assume that a balloon will be extinguished, and indeed all indications, it is not that kind of show.
Turkey is looking to, to dismiss, we find reflected in the banking sector, the different production and service sectors, after Christmas, crisis dynamics are more common in deep analysis is done. İstahdamda recession and the increase in the unemployment rate, indices of economic growth on the one hand, while below, on the other hand, the current account deficit of the budget, the debt can be converted with the plane to keep the limited resources further narrowing, capital and class affect looks. Actual as a further crisis, and the capital of the poor to pay the penance inserted into the yoke of the next worker, the capital of the effects of tears, crocodile gözyaşlarıdır. Indeed, the suggested solutions, to be taken to guarantee financial debt for the government, the public employment and services on behalf of budget discipline, and further restrictions in this context is to prevent the shrinking profitability.
"Crisis and .... "The various discussions and meetings, currently the most common form the agenda for the meeting. In this context, the drug crisis and facing one of the real sector, the effects of the crisis and progress of the potential role of industry as this is spread over three areas.
The first field of the production sector or the pharmaceutical industry. The business sector and the distribution of the second crisis areas in this context is related to pharmaceutical warehouses and pharmacies. The third crisis as field service consumer and a consumer of health services and pharmaceutical services in the treatment of social security services has been organized. Due to page limitations, this article, only the pharmaceutical industry and to discuss the crisis appears likely.
The pharmaceutical industry, as fixed and variable capital, input and context rich with diversity and capacity of continuous financial resources are required to be created is a sector. Labor force employed in the pharmaceutical industry in production, the band, who split with other industrial sectors, and relative importance of qualified, skilled labor is in a process that requires. Workers employed by the dismissal, a balance of properties that qualify element and not enough on the evidence and there is no data, but to collective dismissal is possible to say that it is a sector relatively closed. Factors determine the diversity of the pharmaceutical production jobs, pharmaceutical forms and processes that require high technology for production automation-based robotics is found, only a portion of the tape device management and monitoring of the workers have been installed.
As input for the production of the pharmaceutical industry with the most important expenditure item affecting the pharmaceutical active and help them pay for the materials and the cost of imports, or are purchasing. Number of companies in Turkey, about 200 for sector. Some of them, just import and / or outsourcing of manufacturing firms undertaking the role of the manufacturer. However, a significant sum, with production facilities and, in this framework and help the pharmaceutical active substances and the absolute need in the production of metadata as a drug, it is the number one position in the case of elements are used. Generic drug contains the active ingredient in Turkey until 4000 that, until 8000 in different pharmaceutical drugs are available. In this production process, supplied drugs to the market in Turkey, approximately 70% of the total market to meet the country's other needs that the substitution of imports are. Imported medicines, as input is the currency. Finance capital in a market that is shrinking, in this respect, this market is not being affected by the crisis. Produced directly comes to drugs, the chemical content of pharmaceutical substances, are being imported with foreign currency. Sector, as they decrease in foreign exchange reserves, the level of drug production in the domestic market and reduce shrinkage, and this needs to bring more products to mandatory drug imports. In any case, the situation is clear, specific in terms of drug resistance in patients can not access it can cause depression. On the other hand, foreign currency exchange price differences occur, the results are directly or import products falling in drugs, you are required to price increases and that the public sector and a contraction in terms of budget and more is required to spend. Expenditures of this chapter the most important is to realize the mechanism, will be made to directly raise the cost of medicines is. This means that the crisis of capital from this chapter, in this context, people's pocket and pay taxes through fiscal indicators is.
Drug distribution sector is also associated with the pharmaceutical companies on the basis of sales revenue in the form of direct and indirect sales to shape. Public ihalellerle the drug's direct payments to pharmacies and pharmacy dopoları and the drug's sales revenue for the company's collection, analysis, and their son, including the number of all institutions of the state will make payment to the concerned. State payments are based on calendar late payment and are usually no longer a market undesirable elements has become strange. In the case of companies of scale in terms of capital reserves, the, all conditions were difficult to generate own resources, bank credits are required. Financial crisis, the business capital of the re-creation in this context also have an important relationship.
Turkey 12 billion dollar drug market and the realization of a total world trade hasıla for drug trafficking (2007 world: 712 billion dollars) as a factorial with 1.3% share of luxury size, is one of the world's first 25 markets. This moment of production and trade of the main financial market, in terms of chapters in various forms. Health and treatment services, reflecting the liquidity contraction, drug production and drug in the absence of contraction with the period of increase in drug prices and patient and will be installed in both the public finances. This increases the total of the people is nothing more than piling on again.
This time, the most important indicator of the crisis, the Bretton Woods'un, since the collapse of the Washington consensus, in the steam due to the bottom of the money, the crisis can not be measured at cost. Therefore, the pharmaceutical sector and the financial crisis for workers to reach the ocean depths will require some monitoring to see.
Turkey is looking to, to dismiss, we find reflected in the banking sector, the different production and service sectors, after Christmas, crisis dynamics are more common in deep analysis is done. İstahdamda recession and the increase in the unemployment rate, indices of economic growth on the one hand, while below, on the other hand, the current account deficit of the budget, the debt can be converted with the plane to keep the limited resources further narrowing, capital and class affect looks. Actual as a further crisis, and the capital of the poor to pay the penance inserted into the yoke of the next worker, the capital of the effects of tears, crocodile gözyaşlarıdır. Indeed, the suggested solutions, to be taken to guarantee financial debt for the government, the public employment and services on behalf of budget discipline, and further restrictions in this context is to prevent the shrinking profitability.
"Crisis and .... "The various discussions and meetings, currently the most common form the agenda for the meeting. In this context, the drug crisis and facing one of the real sector, the effects of the crisis and progress of the potential role of industry as this is spread over three areas.
The first field of the production sector or the pharmaceutical industry. The business sector and the distribution of the second crisis areas in this context is related to pharmaceutical warehouses and pharmacies. The third crisis as field service consumer and a consumer of health services and pharmaceutical services in the treatment of social security services has been organized. Due to page limitations, this article, only the pharmaceutical industry and to discuss the crisis appears likely.
The pharmaceutical industry, as fixed and variable capital, input and context rich with diversity and capacity of continuous financial resources are required to be created is a sector. Labor force employed in the pharmaceutical industry in production, the band, who split with other industrial sectors, and relative importance of qualified, skilled labor is in a process that requires. Workers employed by the dismissal, a balance of properties that qualify element and not enough on the evidence and there is no data, but to collective dismissal is possible to say that it is a sector relatively closed. Factors determine the diversity of the pharmaceutical production jobs, pharmaceutical forms and processes that require high technology for production automation-based robotics is found, only a portion of the tape device management and monitoring of the workers have been installed.
As input for the production of the pharmaceutical industry with the most important expenditure item affecting the pharmaceutical active and help them pay for the materials and the cost of imports, or are purchasing. Number of companies in Turkey, about 200 for sector. Some of them, just import and / or outsourcing of manufacturing firms undertaking the role of the manufacturer. However, a significant sum, with production facilities and, in this framework and help the pharmaceutical active substances and the absolute need in the production of metadata as a drug, it is the number one position in the case of elements are used. Generic drug contains the active ingredient in Turkey until 4000 that, until 8000 in different pharmaceutical drugs are available. In this production process, supplied drugs to the market in Turkey, approximately 70% of the total market to meet the country's other needs that the substitution of imports are. Imported medicines, as input is the currency. Finance capital in a market that is shrinking, in this respect, this market is not being affected by the crisis. Produced directly comes to drugs, the chemical content of pharmaceutical substances, are being imported with foreign currency. Sector, as they decrease in foreign exchange reserves, the level of drug production in the domestic market and reduce shrinkage, and this needs to bring more products to mandatory drug imports. In any case, the situation is clear, specific in terms of drug resistance in patients can not access it can cause depression. On the other hand, foreign currency exchange price differences occur, the results are directly or import products falling in drugs, you are required to price increases and that the public sector and a contraction in terms of budget and more is required to spend. Expenditures of this chapter the most important is to realize the mechanism, will be made to directly raise the cost of medicines is. This means that the crisis of capital from this chapter, in this context, people's pocket and pay taxes through fiscal indicators is.
Drug distribution sector is also associated with the pharmaceutical companies on the basis of sales revenue in the form of direct and indirect sales to shape. Public ihalellerle the drug's direct payments to pharmacies and pharmacy dopoları and the drug's sales revenue for the company's collection, analysis, and their son, including the number of all institutions of the state will make payment to the concerned. State payments are based on calendar late payment and are usually no longer a market undesirable elements has become strange. In the case of companies of scale in terms of capital reserves, the, all conditions were difficult to generate own resources, bank credits are required. Financial crisis, the business capital of the re-creation in this context also have an important relationship.
Turkey 12 billion dollar drug market and the realization of a total world trade hasıla for drug trafficking (2007 world: 712 billion dollars) as a factorial with 1.3% share of luxury size, is one of the world's first 25 markets. This moment of production and trade of the main financial market, in terms of chapters in various forms. Health and treatment services, reflecting the liquidity contraction, drug production and drug in the absence of contraction with the period of increase in drug prices and patient and will be installed in both the public finances. This increases the total of the people is nothing more than piling on again.
This time, the most important indicator of the crisis, the Bretton Woods'un, since the collapse of the Washington consensus, in the steam due to the bottom of the money, the crisis can not be measured at cost. Therefore, the pharmaceutical sector and the financial crisis for workers to reach the ocean depths will require some monitoring to see.
England were 117 drug gather
GlaxoSmithKline Pharmaceuticals Industry and Trade Co., England in 2 children under the age of 117 prohibited the use of cough and cold medicine Calpol `` `` reputation among not available, request a prospectus update any of the products and sales in Turkey have said.
GlaxoSmithKline Pharmaceuticals `ndan in the written statement, the United Kingdom in 2 children under the age of the side effects due to `` prospectus updated pharmacy shelves until the collection of the necessary drugs prospectus `` and `` the need to update `` The drugs that contain the 2 separate lists are published hatırlatıldı.
Noted in the list of medicines Calpol `` `` reputation is not included, the United Kingdom by the Medicines Commission reviews the request to update the prospectus of the products in the `` s `` Calpol Night is for sale in Turkey was not mentioned.
`` `` Calpol Night of the formula, and only licensed in Turkey ``` `` containing paracetamol Calpol ``` is different from the recorded statement, the UK Medicines Commission `s, cough and colds with a complaint under the age of 2 children as antifebrile `` or `` only `` paracetamol ibuprofen medications that contain `` hatırlatıldı is recommended.
Noted that this phrase was included:
`` The Ministry of Health `s statement on the subject, the content found in the` drugs `paracetamol any warning / precautions not found. Moreover, our country, except in the UK in relation to the use of drugs such removal, but the agenda is to make new arrangements in the prospectus. Ministry of Health in Turkey since 1991, used with the approval of Calpol ``, `Calpol 6 Plus`, `factors` in Calpol tablets mentioned in the news article parasetamoldür and certainly does not contain active ingredients. ``
GlaxoSmithKline Pharmaceuticals `ndan in the written statement, the United Kingdom in 2 children under the age of the side effects due to `` prospectus updated pharmacy shelves until the collection of the necessary drugs prospectus `` and `` the need to update `` The drugs that contain the 2 separate lists are published hatırlatıldı.
Noted in the list of medicines Calpol `` `` reputation is not included, the United Kingdom by the Medicines Commission reviews the request to update the prospectus of the products in the `` s `` Calpol Night is for sale in Turkey was not mentioned.
`` `` Calpol Night of the formula, and only licensed in Turkey ``` `` containing paracetamol Calpol ``` is different from the recorded statement, the UK Medicines Commission `s, cough and colds with a complaint under the age of 2 children as antifebrile `` or `` only `` paracetamol ibuprofen medications that contain `` hatırlatıldı is recommended.
Noted that this phrase was included:
`` The Ministry of Health `s statement on the subject, the content found in the` drugs `paracetamol any warning / precautions not found. Moreover, our country, except in the UK in relation to the use of drugs such removal, but the agenda is to make new arrangements in the prospectus. Ministry of Health in Turkey since 1991, used with the approval of Calpol ``, `Calpol 6 Plus`, `factors` in Calpol tablets mentioned in the news article parasetamoldür and certainly does not contain active ingredients. ``
Subscribe to:
Posts (Atom)
